Articles citing this paper
cfArticle2ecfc1291681887$funcTITLE@3118ffdb
Julia M. L. Brotherton A B H , John M. Kaldor C and Suzanne M. Garland D E F G
+ Author Affiliations
- Author Affiliations
A Victorian Cytology Service, PO Box 310, East Melbourne, Vic. 8002, Australia.
B National Centre for Immunisation Research and Surveillance, The Children’s Hospital at Westmead, Discipline of Paediatrics and Child Health, School of Public Health, University of Sydney, Sydney, NSW 2006, Australia.
C National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, NSW 2010, Australia.
D Clinical Microbiology and Infectious Diseases, Royal Women’s Hospital, Melbourne, Vic 3052, Australia.
E Department of Clinical Microbiology, Royal Children’s Hospital, Melbourne, Vic. 3052, Australia.
F Faculty of Medicine, Dentistry and Health, Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, Vic. 3053, Australia.
G Murdoch Children’s Research Institute, University of Melbourne, Melbourne, Vic. 3052, Australia.
H Corresponding author. Email: jbrother@vcs.org.au
Sexual Health 7(3) 310-319 https://doi.org/10.1071/SH09137
Submitted: 2 December 2009 Accepted: 13 April 2010 Published: 19 August 2010
37 articles found in Crossref database.
Changes in Incidence of Anogenital Warts Diagnoses After the Introduction of Human Papillomavirus Vaccination in Germany—An Ecologic Study
Mikolajczyk Rafael T.,
Kraut Angela A.,
Horn Johannes,
Schulze-Rath Renate, Garbe Edeltraut
Sexually Transmitted Diseases. 2013 40(1). p.28
A review of data systems for assessing the impact of HPV vaccination in selected high-income countries
Wang Wei (Vivian),
Kothari Smita,
Khoury Hanane,
Niccolai Linda,
Garland Suzanne M.,
Sundström Karin,
de Pouvourville Gérard,
Bonanni Paolo,
Chen Ya-Ting, Franco Eduardo L.
Expert Review of Vaccines. 2023 22(1). p.161
Approaches to monitoring biological outcomes for HPV vaccination: Challenges of early adopter countries
Wong Charlene A.,
Saraiya Mona,
Hariri Susan,
Eckert Linda,
Howlett Roberta I.,
Markowitz Lauri E.,
Brotherton Julia M.L.,
Sinka Katy,
Martinez-Montañez Olga G.,
Kjaer Susanne K., Dunne Eileen F.
Vaccine. 2011 29(5). p.878
Will vaccinated women attend cervical screening? A population based survey of human papillomavirus vaccination and cervical screening among young women in Victoria, Australia
Brotherton Julia M.L., Mullins Robyn M.
Cancer Epidemiology. 2012 36(3). p.298
HPV related surveillance activities in Australia
Brotherton Julia,
Kaldor John M., McIntyre Peter
Vaccine. 2010 28(47). p.7453
Monitoring the impact of human papillomavirus vaccines on high-grade pre-invasive cervical lesions: Designing a framework of linked immunization information system and cancer registry data in Michigan
Potter Rachel C.,
Flagg Elaine W.,
Datta S. Deblina,
Saraiya Mona, Copeland Glenn
Vaccine. 2015 33(11). p.1400
Monitoring the impact of HPV vaccine in males—Considerations and challenges
Brotherton Julia M.L.,
Giuliano Anna R.,
Markowitz Lauri E.,
Dunne Eileen F., Ogilvie Gina S.
Papillomavirus Research. 2016 2 p.106
What do South Asian immigrant women know about HPV, cervical cancer and its early detection: A cross-sectional Australian study
Alam Zufishan,
Dean Judith Ann, Janda Monika
Journal of Migration and Health. 2022 5 p.100102
Advancements in the control of genital human papillomavirus infections and related diseases: highlighting Australia's role
Garland Suzanne M.,
Brotherton Julia M. L.,
Fairley Christopher K.,
Gertig Dorota M., Saville Marion
Sexual Health. 2010 7(3). p.227
Decline in in-patient treatments of genital warts among young Australians following the national HPV vaccination program
Ali Hammad,
Guy Rebecca J,
Wand Handan,
Read Tim RH,
Regan David G,
Grulich Andrew E,
Fairley Christopher K, Donovan Basil
BMC Infectious Diseases. 2013 13(1).
Human papillomavirus 16/18 seroprevalence in unvaccinated women over 30 years with normal cytology and with high grade cervical abnormalities in Australia: results from an observational study
Velentzis Louiza S,
Sitas Freddy,
O’Connell Dianne L,
Darlington-Brown Jessica,
Egger Sam,
Sinha Rohit,
Banks Emily,
Frazer Ian H, Canfell Karen
BMC Infectious Diseases. 2014 14(1).
A significant measure of HPV vaccine effectiveness in a high-risk population in Korea prior to a National Immunization Program
Garland Suzanne
Journal of Gynecologic Oncology. 2020 31(1).
Distribution of human papillomavirus genotypes in Paraguayan women according to the severity of the cervical lesion
Mendoza L.P.,
Arbiza J.,
Paez M.,
Kasamatsu E.,
Castro A.,
Giménez G.,
Basiletti J.,
Gonzalez J.,
Mongelós P., Picconi M.A.
Journal of Medical Virology. 2011 83(8). p.1351
Population-based surveillance for cervical cancer precursors in three central cancer registries, United States 2009
Flagg Elaine W.,
Datta S. Deblina,
Saraiya Mona,
Unger Elizabeth R.,
Peters Edward,
Cole Lauren,
Chen Vivien W.,
Tucker Thomas,
Byrne Mary Jane,
Copeland Glenn,
Silva Won,
Watson Meg, Weinstock Hillard
Cancer Causes & Control. 2014 25(5). p.571
Baseline prevalence and type distribution of Human papillomavirus in sexually active non-vaccinated adolescent girls from Argentina
González Joaquín Víctor,
Deluca Gerardo Daniel,
Liotta Domingo Javier,
Correa Rita Mariel,
Basiletti Jorge Alejandro,
Colucci María Celeste,
Katz Nathalia,
Vizzotti Carla,
Picconi María Alejandra,
Giurgiovich Alejandra,
Alzogaray Gabriela,
Aboslaiman Ricardo,
Chami Cecilia,
Carmona Juan José,
Tappari Néstor,
Morgenstern Andrea,
ElinaTotaro María,
Berner Enrique,
Cramer Viviana,
Vázquez Sandra,
Real Paula,
Kaufman Carlota Lopez,
Kosoy Gabriela,
Katabian Lucía, Severino Maria Silvia
Revista Argentina de Microbiología. 2021 53(1). p.11
High human papillomavirus (HPV)-35 prevalence among South African women with cervical intraepithelial neoplasia warrants attention
Mbulawa Zizipho Z. A.,
Phohlo Keletso,
Garcia-Jardon Mirta,
Williamson Anna-Lise,
Businge Charles B., Tornesello Maria Lina
PLOS ONE. 2022 17(3). p.e0264498
Final analysis of a study assessing genital human papillomavirus genoprevalence in young Australian women, following eight years of a national vaccination program
Garland Suzanne M.,
Cornall Alyssa M.,
Brotherton Julia M.L.,
Wark John D.,
Malloy Michael J., Tabrizi Sepehr N.
Vaccine. 2018 36(23). p.3221
Measuring effectiveness of the cervical cancer vaccine in an Australian setting (the VACCINE study)
Young Elisa J,
Tabrizi Sepehr N,
Brotherton Julia ML,
Wark John D,
Pyman Jan,
Saville Marion,
Wrede C David,
Jayasinghe Yasmin,
Tan Jeffrey,
Gertig Dorota M,
Pitts Marian, Garland Suzanne M
BMC Cancer. 2013 13(1).
Ecological Association of Human Papillomavirus Vaccination with Cervical Dysplasia Prevalence in the United States, 2007–2014
Flagg Elaine W.,
Torrone Elizabeth A., Weinstock Hillard
American Journal of Public Health. 2016 106(12). p.2211
Maximizing the Impact of Human Papillomavirus Vaccination
Garland Suzanne M, Machalek Dorothy A
Clinical Infectious Diseases. 2017 65(6). p.890
Tracking type specific prevalence of human Papillomavirus in cervical pre-cancer: a novel sampling strategy
Waters Edward K,
Kaldor John,
Hamilton Andrew J,
Smith Anthony MA,
Philp David J,
Donovan Basil, Regan David G
BMC Medical Research Methodology. 2012 12(1).
Genital HPV types in Australia
Brotherton Julia,
Garland Suzanne, Donovan Basil
The Lancet Infectious Diseases. 2012 12(2). p.102
Primary prophylactic human papillomavirus vaccination programs: future perspective on global impact
Brotherton Julia ML, Gertig Dorota M
Expert Review of Anti-infective Therapy. 2011 9(8). p.627
High human papillomavirus prevalence among females attending high school in the Eastern Cape Province of South Africa
Mbulawa Zizipho Z. A.,
Somdyala Nontuthuzelo I.,
Mabunda Sikhumbuzo A.,
Williamson Anna-Lise, Angeletti Peter C.
PLOS ONE. 2021 16(6). p.e0253074
Evaluating Human Papillomavirus Vaccination Programs
Donovan Basil, Guy Rebecca J.
Sexually Transmitted Diseases. 2013 40(4). p.290
Decline in prevalence of human papillomavirus infection following vaccination among Australian Indigenous women, a population at higher risk of cervical cancer: The VIP-I study
McGregor Skye,
Saulo Dina,
Brotherton Julia M.L.,
Liu Bette,
Phillips Samuel,
Skinner S. Rachel,
Luey Michele,
Oliver Lisa,
Stewart Mary,
Tabrizi Sepehr N.,
Garland Suzanne, Kaldor John M.
Vaccine. 2018 36(29). p.4311
Genital warts
Steben Marc, Garland Suzanne M.
Best Practice & Research Clinical Obstetrics & Gynaecology. 2014 28(7). p.1063
Fall in Human Papillomavirus Prevalence Following a National Vaccination Program
Tabrizi S. N.,
Brotherton J. M. L.,
Kaldor J. M.,
Skinner S. R.,
Cummins E.,
Liu B.,
Bateson D.,
McNamee K.,
Garefalakis M., Garland S. M.
Journal of Infectious Diseases. 2012 206(11). p.1645
Prevalence of Anogenital Warts Among Participants in Private Health Plans in the United States, 2003–2010: Potential Impact of Human Papillomavirus Vaccination
Flagg Elaine W.,
Schwartz Robert, Weinstock Hillard
American Journal of Public Health. 2013 103(8). p.1428
How to best measure the effectiveness of male human papillomavirus vaccine programmes?
Garland S.M.,
Molesworth E.G.,
Machalek D.A.,
Cornall A.M., Tabrizi Sepehr N.
Clinical Microbiology and Infection. 2015 21(9). p.834
Vaccines (2013)
Differential misclassification between self-reported status and official HPV vaccination records in Japan: Implications for evaluating vaccine safety and effectiveness
Yamaguchi Manako,
Sekine Masayuki,
Kudo Risa,
Adachi Sosuke,
Ueda Yutaka,
Miyagi Etsuko,
Hara Megumi,
Hanley Sharon J.B., Enomoto Takayuki
Papillomavirus Research. 2018 6 p.6
Human papillomavirus vaccination: the population impact
Lee Lai-yang, Garland Suzanne M.
F1000Research. 2017 6 p.866
Screening for Human Papillomavirus in a Low- and Middle-Income Country
Atkinson Aaron E.,
Mandujano Carlos Alberto Matute,
Bejarano Suyapa,
Kennedy Linda S., Tsongalis Gregory J.
Journal of Global Oncology. 2019 (5).
Distribution of Human Papillomavirus Genotypes in Iranian Women According to the Severity of the Cervical Lesion
Salehi-Vaziri Mostafa,
Sadeghi Farzin,
Hashemi Firoozeh Sadat,
Haeri Hayedeh,
Bokharaei-Salim Farah,
Monavari Seyed Hamidreza, Keyvani Hossein
Iranian Red Crescent Medical Journal. 2016 18(4).
Human Papillomavirus Vaccines (2011)
Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand
Simonella Leonardo M,
Lewis Hazel,
Smith Megan,
Neal Harold,
Bromhead Collette, Canfell Karen
BMC Infectious Diseases. 2013 13(1).
